Noncirrhotic portal hypertension: recent concepts

Area of Science:

• Gastroenterology
• Vascular Medicine
• Pathology

Background:

• Non-cirrhotic portal hypertension (NCPH) arises from portal vein obliteration, frequently preceded by inflammatory endothelial injury.
• Progressive obliteration leads to venous stasis and portal hypertension, often with superimposed portal vein thrombosis (PVT) before clinical manifestation.
• Hypercoagulable states are significant contributing factors in the development of NCPH and PVT.

Purpose of the Study:

• To elucidate the pathophysiology of non-cirrhotic portal hypertension (NCPH) and its association with portal vein thrombosis (PVT).
• To highlight diagnostic strategies, emphasizing the exclusion of cirrhosis and the role of imaging and laboratory tests.
• To identify potential areas for advancement in the diagnosis and understanding of the causes of PVT and NCPH.

Main Methods:

• Diagnostic criteria for NCPH, including exclusion of cirrhosis.
• Biopsy findings such as focal atrophy and nodular hyperplasia as indicators of small vessel obliteration.
• Doppler ultrasound for assessing portal and hepatic vein vascular disease distribution.
• Laboratory investigations for hypercoagulable disorders, systemic inflammatory diseases, and local inflammatory conditions.
• Advanced imaging techniques like MRI and intravascular ultrasonography for PVT diagnosis.

Main Results:

• Focal atrophy and nodular hyperplasia on biopsy can suggest small vessel obliteration.
• Doppler ultrasound is crucial for documenting the extent of vascular disease in portal and hepatic veins.
• Comprehensive etiological investigation includes tests for hypercoagulable states, autoimmune diseases, toxin exposure, and primary biliary cirrhosis or sarcoidosis.

Conclusions:

• Accurate diagnosis of NCPH hinges on excluding cirrhosis and identifying underlying causes like hypercoagulability and inflammatory conditions.
• Advanced imaging technologies (MRI, ultrasound) are pivotal for improving the diagnosis of acute and recanalized PVT.
• Further research into novel diagnostic tests for hypercoagulable states is essential for advancing the understanding and treatment of PVT and NCPH.